Opportunities for Interactions with FDA: CDER and CDRH Perspectives - Oritavancin - Document - PDFSEARCH.IO

First Page	Meta Content
	Opportunities for Interactions with FDA: CDER and CDRH Perspectives Add to Reading List Open Document File Size: 1.006,99 KB Share Result on Facebook Organization Center for Devices and Radiological Health / FDA / Transplant and Ophthalmology Products office of Antimicrobial Products / Center for Biologics Evaluation and Research / Project Management Staff Division of Transplant / office of Device Evaluation / office of New Drugs / Food and Drug Administration / / Person Judit Milstein / Soma Kalb / / Position Acting Director / Investigational Device Exemption Program Program Operations / CDER Chief / / Product Soma / / Technology pdf / / URL http / SocialTag Health Prescription Drug User Fee Act Investigational Device Exemption Center for Devices and Radiological Health FDA Special Protocol Assessment Center for Drug Evaluation and Research Premarket approval Oritavancin Food and Drug Administration Pharmaceutical sciences

Opportunities for Interactions with FDA: CDER and CDRH PerspectivesAdd to Reading List